Youth Transition Medicine Is New and Experimental

The use of puberty blockers and cross-sex hormones in young people is very new—roughly 80% of research on youth medical transition was done in the last 10 years—and the lack of authoritative long-term outcome studies makes such care risky and, specifically, experimental.